TFX Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Teleflex Incorporated Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$178.25 |
52 Week High | US$256.85 |
52 Week Low | US$171.69 |
Beta | 1.15 |
1 Month Change | -7.02% |
3 Month Change | -27.51% |
1 Year Change | -28.97% |
3 Year Change | -46.17% |
5 Year Change | -52.00% |
Change since IPO | 47,480.03% |
Recent News & Updates
Teleflex Incorporated: Compelling Only On One Metric
Dec 11Why We're Not Concerned About Teleflex Incorporated's (NYSE:TFX) Share Price
Dec 09Here's What Analysts Are Forecasting For Teleflex Incorporated (NYSE:TFX) After Its Third-Quarter Results
Nov 02Recent updates
Teleflex Incorporated: Compelling Only On One Metric
Dec 11Why We're Not Concerned About Teleflex Incorporated's (NYSE:TFX) Share Price
Dec 09Here's What Analysts Are Forecasting For Teleflex Incorporated (NYSE:TFX) After Its Third-Quarter Results
Nov 02Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?
Sep 30Returns On Capital At Teleflex (NYSE:TFX) Paint A Concerning Picture
Sep 14Market Participants Recognise Teleflex Incorporated's (NYSE:TFX) Earnings
Aug 29Teleflex Reinvesting In Growth, But Valuation Isn't That Compelling
Aug 26Is Teleflex Incorporated (NYSE:TFX) Potentially Undervalued?
Jul 29Here's Why Teleflex (NYSE:TFX) Can Manage Its Debt Responsibly
Jun 20Investors Could Be Concerned With Teleflex's (NYSE:TFX) Returns On Capital
Jun 05Is Teleflex Incorporated (NYSE:TFX) Trading At A 39% Discount?
May 21Teleflex: Compelling, Despite Some Operational Hiccups
May 06What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?
Apr 21Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Mar 06Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate
Feb 19Is Teleflex (NYSE:TFX) A Risky Investment?
Feb 02Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult
Jan 17Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Dec 31Teleflex Shares Hit Hard As Growth Concerns Stack Up
Oct 13Teleflex: Flexing Its Muscles A Bit
Jul 27Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings
Jun 22Teleflex's 2 catheter devices get FDA clearance
Feb 22Teleflex Already Getting A Pretty Good Benefit Of The Doubt
Jan 11Shareholder Returns
TFX | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0.6% | -1.2% | -2.7% |
1Y | -29.0% | 10.0% | 23.4% |
Return vs Industry: TFX underperformed the US Medical Equipment industry which returned 10% over the past year.
Return vs Market: TFX underperformed the US Market which returned 23.4% over the past year.
Price Volatility
TFX volatility | |
---|---|
TFX Average Weekly Movement | 5.1% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: TFX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1943 | 14,500 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
TFX fundamental statistics | |
---|---|
Market cap | US$8.27b |
Earnings (TTM) | US$238.01m |
Revenue (TTM) | US$3.03b |
34.8x
P/E Ratio2.7x
P/S RatioIs TFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TFX income statement (TTM) | |
---|---|
Revenue | US$3.03b |
Cost of Revenue | US$1.33b |
Gross Profit | US$1.69b |
Other Expenses | US$1.46b |
Earnings | US$238.01m |
Last Reported Earnings
Sep 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.12 |
Gross Margin | 55.99% |
Net Profit Margin | 7.87% |
Debt/Equity Ratio | 40.4% |
How did TFX perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield27%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 23:03 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/29 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Teleflex Incorporated is covered by 36 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Matthew Taylor | Barclays |
Craig Bijou | BofA Global Research |